News
Michael J. Mauro, MD, leader of the Myeloproliferative Neoplasms Program, Leukemia Service, at Memorial Sloan Kettering Cancer Center, discusses the current understanding of TKI discontinuation ...
4d
News-Medical.Net on MSNGenetic fusion drives unexpectedly fast growth in chronic myeloid leukemiaA new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in ...
Zhu and colleagues show that a subpopulation of spleen-derived fibroblasts secrete Gremlin 1, which suppresses chronic myeloid leukemia progression by inducing leukemia stem cell apoptosis through ...
Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...
Exposures to moderate-to-high doses of ionizing radiation have been associated with an increased risk of acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic ...
17d
News Medical on MSNDigital PCR can reliably determine if chronic myeloid leukemia patients in remission can successfully discontinue drug treatmentABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results